ArticleBiological trace element research2025
Exploring Potential Health Risk of Chenxiang Huaqi Tablets Based on Inorganic Elemental Evaluation Using ICP-MS.
Article in Biological trace element research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chenxiang Huaqi Tablet (CXHQT) is a Chinese patent medicine preparation composed of 10 traditional Chinese herbs. In this study, the concentrations of 23 inorganic elements in CXHQT were determined by inductively coupled plasma mass spectrometry (ICP-MS). The fingerprint of the elements was established, the chemometrics and element correlation analysis were carried out, and the health risk assessment of heavy metals and harmful elements was performed. The results revealed that there were certain differences in the content of inorganic elements in 15 batches of CXHQT manufactured by the same pharmaceutical company. Pb, U, Al, Ga, Cd, As, Co, Ni, and Fe were identified as characteristic elements contributing to quality differences by chemometric analysis. In addition, the results of health risk assessment, such as total hazard index (HI) and total carcinogenic risk (TCR), indicated that the content of Al, Cr, Mn, Co, Ni, Cu, Zn, As, Sr, Cd, and Pb in CXHQT was within the normal range and would not endanger human health. This study provided a scientific and comprehensive reference for evaluation of inorganic elements and safety in CXHQT.
Indexed as
Identifiers
40301210What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.